Syquant Capital Sas’s Regeneron Pharmaceuticals Position
Does Syquant Capital Sas own Regeneron Pharmaceuticals (REGN)? Not currently — the last reported position was 10.3K shares worth $6M in Q2 2020; the fund’s latest 13F (Q2 2026) no longer reports it.
Position Value
$6M
Q2 2020
Shares
10.3K
% of Portfolio
+2.99%
Quarters Held
1
position exited
Position History REGN
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2020 | 10.3K | $6M | +2.99% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Syquant Capital Sas’s full portfolio or all institutional holders of REGN.